NYSE:TAK
Takeda Pharmaceutical Company Limited
- Stock
Last Close
4,205.00
15/05 06:15
Market Cap
6.84T
Beta: 0.68
Volume Today
2.82M
Avg: 2.34M
PE Ratio
18.10
PFCF: −50.39
Dividend Yield
0.01%
Payout:161.87%
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 241.93B - | 258.34B 6.78% | 258.18B 0.06% | 240.15B 6.98% | 219.62B 8.55% | 599.84B 173.13% | 873.17B 45.57% | 756.74B 13.33% | 803.52B 6.18% | 919.81B 14.47% | |
average payables | 151.80B - | 177.84B 17.16% | 180.94B 1.74% | 215.86B 19.30% | 240.44B 11.39% | 226.30B 5.88% | 265.58B 17.36% | 331.33B 24.76% | 430.07B 29.80% | 582.76B 35.51% | |
average receivables | 514.17B - | 454.75B 11.56% | 448.70B 1.33% | 437.67B 2.46% | 436.79B 0.20% | 588.96B 34.84% | 767.02B 30.23% | 798.82B 4.15% | 768.55B 3.79% | 703.03B 8.52% | |
book value per share | 3.13K - | 2.72K 13.17% | 2.49K 8.53% | 2.43K 2.44% | 2.56K 5.48% | 5.37K 109.77% | 3.03K 43.47% | 3.31K 9.18% | 3.63K 9.75% | 4.09K 12.65% | |
capex per share | -99.46 - | -138.25 39.00% | -108.24 21.70% | -143.42 32.50% | -164.27 14.53% | -139.49 15.09% | -139.81 0.23% | -151.39 8.28% | -118.99 21.40% | -408.36 243.19% | |
capex to depreciation | -0.36 - | -0.42 14.47% | -0.43 3.19% | -0.50 16.96% | -0.70 40.05% | -0.49 30.10% | -0.37 24.22% | -0.42 13.27% | -0.32 24.49% | -0.95 198.97% | |
capex to operating cash flow | -0.53 - | -0.60 12.53% | -3.33 458.86% | -0.43 87.12% | -0.34 20.81% | -0.41 20.28% | -0.33 20.38% | -0.23 28.04% | -0.17 29.18% | -0.65 291.50% | |
capex to revenue | -0.05 - | -0.06 31.75% | -0.05 23.22% | -0.06 37.76% | -0.07 12.00% | -0.06 11.73% | -0.07 3.44% | -0.07 11.79% | -0.05 29.51% | -0.16 201.85% | |
cash per share | 1.08K - | 907.20 15.84% | 714.37 21.26% | 481.55 32.59% | 480.48 0.22% | 754.43 57.01% | 419.62 44.38% | 642.01 53.00% | 559.64 12.83% | 356.81 36.24% | |
days of inventory on hand | 189.35 - | 183.80 2.93% | 173.17 5.79% | 147.82 14.63% | 156.73 6.02% | 545.96 248.35% | 254.42 53.40% | 276.74 8.78% | 281.35 1.66% | 289.42 2.87% | |
days payables outstanding | 137.66 - | 119.65 13.08% | 130.27 8.88% | 157.18 20.66% | 176.83 12.50% | 117.49 33.56% | 106.78 9.11% | 126.22 18.20% | 170.26 34.89% | 190.48 11.88% | |
days sales outstanding | 95.51 - | 95.84 0.35% | 86.95 9.28% | 93.73 7.79% | 88.40 5.69% | 130.38 47.49% | 87.05 33.23% | 92.76 6.56% | 74.08 20.14% | 61.78 16.61% | |
debt to assets | 0.19 - | 0.17 9.80% | 0.20 18.33% | 0.26 30.84% | 0.24 8.68% | 0.41 72.72% | 0.40 4.17% | 0.36 9.63% | 0.33 8.15% | 0.31 4.78% | |
debt to equity | 0.35 - | 0.34 1.94% | 0.39 15.51% | 0.60 53.31% | 0.49 18.35% | 1.11 125.87% | 1.08 3.26% | 0.90 16.90% | 0.76 14.67% | 0.69 9.80% | |
dividend yield | 0.04 - | 0.03 18.42% | 0.04 17.09% | 0.03 1.32% | 0.04 1.07% | 0.03 7.63% | 0.05 69.39% | 0.05 17.02% | 0.05 13.94% | 0.04 20.19% | |
earnings yield | 0.03 - | -0.03 211.89% | 0.02 164.43% | 0.03 41.34% | 0.05 64.10% | 0.02 46.47% | 0.01 65.26% | 0.06 603.35% | 0.04 30.36% | 0.05 11.64% | |
enterprise value | 4.06T - | 4.79T 18.21% | 4.34T 9.42% | 4.91T 13.05% | 4.74T 3.50% | 9.46T 99.72% | 9.61T 1.52% | 9.89T 2.99% | 8.96T 9.39% | 10.60T 18.23% | |
enterprise value over ebitda | 10.01 - | 32.31 222.89% | 12.41 61.58% | 12.61 1.57% | 10.99 12.87% | 25.14 128.84% | 13.97 44.45% | 8.42 39.68% | 8.52 1.13% | 8.77 2.89% | |
ev to operating cash flow | 27.34 - | 26.27 3.92% | 170.38 548.55% | 18.79 88.97% | 12.54 33.25% | 28.81 129.74% | 14.34 50.21% | 9.79 31.77% | 7.98 18.44% | 10.85 35.89% | |
ev to sales | 2.40 - | 2.70 12.49% | 2.40 10.90% | 2.83 17.96% | 2.68 5.59% | 4.51 68.61% | 2.92 35.31% | 3.09 5.99% | 2.51 18.81% | 2.63 4.77% | |
free cash flow per share | 88.43 - | 93.84 6.12% | -75.73 180.69% | 191.19 352.47% | 319.66 67.20% | 202.15 36.76% | 290.29 43.60% | 495.81 70.80% | 599.34 20.88% | 221.33 63.07% | |
free cash flow yield | 0.02 - | 0.02 13.46% | -0.01 194.25% | 0.04 347.98% | 0.06 68.68% | 0.04 28.60% | 0.09 99.29% | 0.12 41.78% | 0.17 37.71% | 0.05 70.30% | |
graham net net | -909.87 - | -1.14K 25.12% | -1.02K 10.04% | -2.03K 97.99% | -1.65K 18.79% | -7.21K 337.57% | -4.16K 42.32% | -3.68K 11.49% | -3.61K 1.77% | -3.90K 7.80% | |
graham number | 3.08K - | 3.37K 9.15% | 2.39K 28.96% | 2.83K 18.49% | 3.71K 30.99% | 3.70K 0.26% | 1.39K 62.38% | 4.24K 204.15% | 3.47K 18.09% | 4.34K 25.06% | |
income quality | 1.35 - | -1.28 194.25% | 0.31 123.93% | 2.26 640.98% | 2.02 10.56% | 3.01 48.89% | 15.12 401.86% | 2.69 82.23% | 4.88 81.57% | 3.08 36.84% | |
intangibles to total assets | 0.43 - | 0.41 3.95% | 0.40 2.89% | 0.48 20.44% | 0.50 3.78% | 0.65 30.69% | 0.64 1.85% | 0.62 3.63% | 0.62 1.48% | 0.65 3.99% | |
interest coverage | 4.53 - | -3.93 186.71% | 4.10 204.22% | 6.70 63.62% | 7.57 12.96% | 4.26 43.80% | 0.61 85.70% | 2.05 236.61% | 2.77 35.04% | 2.89 4.50% | |
interest debt per share | 1.13K - | 969.30 14.09% | 1.02K 5.30% | 1.50K 46.52% | 1.30K 12.86% | 6.03K 362.80% | 3.38K 44.01% | 3.13K 7.40% | 2.89K 7.70% | 2.93K 1.65% | |
inventory turnover | 1.93 - | 1.99 3.02% | 2.11 6.14% | 2.47 17.14% | 2.33 5.68% | 0.67 71.29% | 1.43 114.59% | 1.32 8.07% | 1.30 1.64% | 1.26 2.79% | |
invested capital | 0.35 - | 0.34 1.94% | 0.39 15.51% | 0.60 53.31% | 0.49 18.35% | 1.11 125.87% | 1.08 3.26% | 0.90 16.90% | 0.76 14.67% | 0.69 9.80% | |
market cap | 3.86T - | 4.72T 22.15% | 4.03T 14.65% | 4.08T 1.44% | 4.05T 0.92% | 4.41T 9.07% | 5.15T 16.70% | 6.22T 20.84% | 5.47T 12.14% | 6.75T 23.43% | |
net current asset value | -435.97B - | -569.94B 30.73% | -439.10B 22.96% | -1.15T 161.03% | -1.01T 11.86% | -5.66T 460.07% | -5.62T 0.60% | -5.02T 10.70% | -4.90T 2.42% | -5.21T 6.21% | |
net debt to ebitda | 0.48 - | 0.52 8.77% | 0.91 73.98% | 2.12 134.10% | 1.60 24.40% | 13.41 737.02% | 6.48 51.71% | 3.12 51.77% | 3.32 6.34% | 3.18 4.18% | |
net income per share | 135.10 - | -185.37 237.21% | 102.26 155.17% | 147.15 43.90% | 239.35 62.65% | 113.50 52.58% | 28.41 74.97% | 240.72 747.29% | 147.14 38.87% | 204.29 38.84% | |
operating cash flow per share | 187.89 - | 232.09 23.52% | 32.52 85.99% | 334.61 929.05% | 483.92 44.62% | 341.64 29.40% | 430.10 25.89% | 647.20 50.48% | 718.33 10.99% | 629.69 12.34% | |
payables turnover | 2.65 - | 3.05 15.05% | 2.80 8.15% | 2.32 17.12% | 2.06 11.11% | 3.11 50.51% | 3.42 10.03% | 2.89 15.40% | 2.14 25.87% | 1.92 10.62% | |
receivables turnover | 3.82 - | 3.81 0.35% | 4.20 10.22% | 3.89 7.23% | 4.13 6.03% | 2.80 32.20% | 4.19 49.77% | 3.93 6.16% | 4.93 25.22% | 5.91 19.91% | |
research and ddevelopement to revenue | 0.20 - | 0.21 6.45% | 0.19 10.95% | 0.18 5.79% | 0.18 1.94% | 0.18 4.46% | 0.15 14.81% | 0.14 4.72% | 0.15 3.41% | 0.16 6.68% | |
return on tangible assets | 0.04 - | -0.06 241.20% | 0.03 160.57% | 0.05 45.55% | 0.09 78.70% | 0.02 75.17% | 0.01 57.59% | 0.08 693.11% | 0.05 38.60% | 0.06 39.33% | |
revenue per share | 2.14K - | 2.26K 5.50% | 2.31K 1.98% | 2.22K 3.82% | 2.27K 2.26% | 2.18K 3.81% | 2.11K 3.11% | 2.05K 3.14% | 2.28K 11.50% | 2.60K 13.70% | |
roe | 0.04 - | -0.07 258.02% | 0.04 160.31% | 0.06 47.50% | 0.09 54.20% | 0.02 77.39% | 0.01 55.72% | 0.07 676.04% | 0.04 44.31% | 0.05 23.24% | |
roic | 0.03 - | -0.04 253.77% | 0.03 175.20% | 0.04 23.93% | 0.07 68.58% | 0.02 69.02% | -0.01 134.55% | 0.05 815.23% | 0.03 34.45% | 0.04 10.46% | |
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 3.13K - | 2.72K 13.17% | 2.49K 8.53% | 2.43K 2.44% | 2.56K 5.48% | 5.37K 109.77% | 3.03K 43.47% | 3.31K 9.18% | 3.63K 9.75% | 4.09K 12.65% | |
stock based compensation to revenue | -0.13 - | -0.06 48.68% | -0.03 59.64% | -0.09 252.74% | 0.01 111.38% | 0.01 8.89% | 0.01 7.60% | 0.01 33.10% | 0.01 3.19% | 0.02 23.96% | |
tangible asset value | 590.37B - | 444.88B 24.64% | 488.76B 9.86% | -139.58B 128.56% | -26.10B 81.30% | -3.86T 14,680.61% | -3.46T 10.41% | -2.77T 19.98% | -2.54T 8.07% | -2.71T 6.41% | |
tangible book value per share | 747.80 - | 565.72 24.35% | 623.46 10.21% | -178.70 128.66% | -33.43 81.29% | -4.01K 11,903.28% | -2.22K 44.69% | -1.77K 20.23% | -1.63K 8.15% | -1.74K 7.21% | |
working capital | 789.78B - | 503.25B 36.28% | 516.57B 2.65% | -105.43B 120.41% | 341.30B 423.72% | 539.73B 58.14% | 293.53B 45.61% | 939.72B 220.14% | 447.91B 52.34% | -83.98B 118.75% |
All numbers in USD (except ratios and percentages)